Notice of Change to Application Types for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)"

Notice Number: NOT-AT-19-016


Key Dates
Release Date: January 22, 2019

Related Announcements

PAR-18-696
NOT-AT-18-010 - Rescinded

Issued by
National Center for Complementary and Integrative Health (NCCIH)

Purpose

The purpose of this Notice is to inform applicants that The National Center for Complementary and Integrative Health (NCCIH) will accept Revision applications and will not accept Renewal applications for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)", since renewals are not an allowable application type for the UG3/UH3 activity code. Investigators who are currently funded by NCCIH on a UG3/UH3 award can use a Revision application to submit ancillary studies to ongoing clinical trial.

The Funding Opportunity Announcement (FOA) currently reads as:

Key Dates
Application Due Date(s)
New Applications : June 7, 2018; February 7, 2019; and October 7, 2019
Resubmission and Renewal Applications
: June 21, 2018; February 21, 2019; and October 21, 2019


Section II. Award Information
Application Types Allowed
New
Resubmission
Renewal

The Funding Opportunity Announcement (FOA) is modified to reads as:

Key Dates
Application Due Date(s)
New Applications : June 7, 2018; February 7, 2019; and October 7, 2019
Revision and Resubmission Applications: June 21, 2018; February 21, 2019; and October 21, 2019


Section II. Award Information
Application Types Allowed
New
Resubmission
Revision

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Wendy Weber, ND, PhD, MPH
National Center for Complementary and Integrative Health (NCCIH)
Telephone:301-402-1272
Email:[email protected]